חיפוש
22 מחקרים תואמים למסננים אלה. מציג 1–22 מתוך 22 מחקרים
| מספר רישום | מחקר | מצב | שלב | גיוס | אתרים / מדינות | שנת התחלה | עודכן לאחרונה | פעולות |
|---|---|---|---|---|---|---|---|---|
| NCT07570316 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease The main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. It will look at how efgartigimod is distributed and eliminated in the body, how it changes antibody l… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 35 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 230יעד | 35 / 3 | 2026 | 3 בנוב׳ 2026 | |
| NCT06932263 | Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Hutchinson, Kansas, United States — במרחק 36 ק"מ · 223 מרכזים בסך הכול | מגייס | שלב 2 | 540יעד | 223 / 21 | 2025 | 30 באוק׳ 2026 | |
| NCT05491525 | Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 38 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 / שלב 3 | 71יעד | 38 / 16 | 2022 | 15 ביוני 2026 | |
| NCT07764978 | Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT This is a randomised, multicentre, controlled, open-label, Phase III global study comparing the efficacy and safety of standard induction regimens (IsaVRd and DRd) followed by AZD0120 versus standard induction regimens followed by continuous therapy (IsaRd and DRd) in participants with newly diagnos… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 124 מרכזים בסך הכול | מגייס | שלב 3 | 750יעד | 124 / 15 | 2026 | 14 באוג׳ 2026 | |
| NCT07439653 | A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma A Phase 1/2 study to evaluate safety, tolerability, and anticancer activity of TORL-5-700 as a monotherapy and in combination in R/R NHL ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 9 מרכזים בסך הכול | מגייס | שלב 1 / שלב 2 | 155יעד | 9 / 1 | 2026 | 28 בספט׳ 2026 | |
| NCT06172296 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 180 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 478יעד | 180 / 5 | 2024 | 30 באוק׳ 2026 | |
| NCT04566328 | Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell g… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Kingman, Kansas, United States — במרחק 28 ק"מ · 647 מרכזים בסך הכול | מגייס | שלב 3 | 1,450יעד | 647 / 2 | 2021 | 16 בנוב׳ 2026 | |
| NCT07353931 | Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight The YDAN master protocol will support two independent studies, J3R-MC-YOA1 and J3R-MC-YOA2. Each study will investigate how well and safely Eloralintide (LY3841136) works in adults with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last abo… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Newton, Kansas, United States — במרחק 53 ק"מ · 147 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 900יעד | 147 / 13 | 2026 | 4 בנוב׳ 2026 | |
| NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) The purpose of this clinical study is to learn about the safety and effects of berobenatide (PF-08653944) for the treatment of knee osteoarthritis in adults with overweight or obesity. The study will last 52 weeks and compare the effects of berobenatide compared to placebo on knee pain, physical fun… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 40 מרכזים בסך הכול | מגייס | שלב 3 | 656יעד | 40 / 2 | 2026 | 5 בנוב׳ 2026 | |
| NCT06876714 | ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab This phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive (+) breast cancer in patients that had a pathologic complete response (pCR) after preoperative (neoadjuvant) chemotherap… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Kingman, Kansas, United States — במרחק 28 ק"מ · 702 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 1,524יעד | 702 / 2 | 2025 | 2 באוק׳ 2026 | |
| NCT07293247 | A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment This phase II trial compares the effect of intensity-modulated post-operative radiation therapy (I²-PORT) followed by standard of care therapy (chemotherapy or immunotherapy) to standard of care therapy alone in treating patients with non-small cell lung cancer (NSCLC) who have remaining lymph node… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 125 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 | 164יעד | 125 / 1 | 2026 | 3 בנוב׳ 2026 | |
| NCT05675410 | A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in improving survival in patients with stage I and II classical Hodgkin lymphoma. Brentuximab vedotin is… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 419 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 1,875יעד | 419 / 3 | 2023 | 12 בנוב׳ 2026 | |
| NCT05812807 | Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab This phase III trial compares the effect of continuation of treatment with pembrolizumab (usual approach) to observation only at preventing cancer from coming back in patients with early-stage triple-negative breast cancer (TNBC) who achieved a pathologic complete response after preoperative chemoth… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Kingman, Kansas, United States — במרחק 28 ק"מ · 846 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 1,295יעד | 846 / 3 | 2023 | 5 באוג׳ 2026 | |
| NCT03959085 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab ozogamicin is a monoclonal antibody, which is a type of protei… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 231 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 5,951יעד | 231 / 5 | 2019 | 25 באוג׳ 2026 | |
| NCT05624996 | Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation therapy \[IGRT\] and chemotherapy followed by immunotherapy with durvalumab or targeted therapy with osimertinib) versus the usual treatment alone… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 477 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 474יעד | 477 / 2 | 2023 | 17 באוג׳ 2026 | |
| NCT07578116 | Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis This phase III trial evaluates the effect of adding locoregional therapy (surgery and radiation) and metastasis-directed stereotactic body radiation therapy (SBRT) to standard systemic therapy following standard HER2-targeted systemic therapy, compared to standard systemic therapy alone, in treating… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 59 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 562יעד | 59 / 1 | 2027 | 13 באוק׳ 2026 | |
| NCT07321652 | Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL This phase III trial compares the effect of adding sonrotoclax to zanubrutinib versus zanubrutinib alone for the treatment of patients with untreated chronic lymphoblastic leukemia (CLL)/small lymphocytic lymphoma (SLL). Sonrotoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhib… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Kingman, Kansas, United States — במרחק 28 ק"מ · 261 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 466יעד | 261 / 1 | 2026 | 3 בנוב׳ 2026 | |
| NCT04267848 | Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immun… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Kingman, Kansas, United States — במרחק 28 ק"מ · 1,151 מרכזים בסך הכול | מגייס | שלב 3 | 1,210יעד | 1,151 / 2 | 2020 | 12 בנוב׳ 2026 | |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia This phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a chemotherapy dr… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 460 מרכזים בסך הכול | מגייס | שלב 3 | 303יעד | 460 / 2 | 2017 | 3 בנוב׳ 2026 | |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 279 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | 75,000יעד | 279 / 6 | 2015 | 19 בנוב׳ 2026 | ||
| NCT03866382 | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blo… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Kingman, Kansas, United States — במרחק 28 ק"מ · 582 מרכזים בסך הכול | מגייס | שלב 2 | 314יעד | 582 / 2 | 2019 | 18 בנוב׳ 2026 | |
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 751 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | 2,900יעד | 751 / 1 | 2022 | 4 בנוב׳ 2026 |